PHASE II TRIAL OF A SURVIVIN VACCINE (SurVaxM) FOR NEWLY DIAGNOSED GLIOBLASTOMA

被引：0
|
作者：
Ahluwalia, Manmeet [1 ]
Reardon, David [2 ]
Abad, Ajay [3 ]
Curry, William [4 ]
Wong, Eric [5 ]
Peereboom, David [1 ]
Belal, Ahmed [3 ]
Qiu, Jingxin [3 ]
Mogensen, Kathleen [3 ]
Schilero, Cathy [1 ]
Casucci, Danielle [3 ]
Mechtler, Laszlo [3 ]
Uhlmann, Erik [3 ]
Ciesielski, Michael [3 ]
Fenstermaker, Robert [3 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
[4] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02115 USA
[5] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
来源：
NEURO-ONCOLOGY | 2018年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ATIM-41
引用
收藏
页码：10 / 11
页数：2
相关论文
共 50 条
  • [31] A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
    Gilbert, Mark R.
    Dignam, James J.
    Armstrong, Terri S.
    Wefel, Jeffrey S.
    Blumenthal, Deborah T.
    Vogelbaum, Michael A.
    Colman, Howard
    Chakravarti, Arnab
    Pugh, Stephanie
    Won, Minhee
    Jeraj, Robert
    Brown, Paul D.
    Jaeckle, Kurt A.
    Schiff, David
    Stieber, Volker W.
    Brachman, David G.
    Werner-Wasik, Maria
    Tremont-Lukats, Ivo W.
    Sulman, Erik P.
    Aldape, Kenneth D.
    Curran, Walter J., Jr.
    Mehta, Minesh P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (08): : 699 - 708
  • [32] PHASE I/IIA TRIAL OF AUTOLOGOUS FORMALIN-FIXED TUMOR VACCINE IN TREATMENT OF NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
    Muragaki, Yoshihiro
    Maruyama, Takashi
    Iseki, Hiroshi
    Takakura, Kintomo
    Tanaka, Masahiko
    Shinohara, Chie
    Tsuboi, Koji
    Yamamoto, Tetsuya
    Matsumura, Akira
    Matsutani, Masao
    Karasawa, Katsuyuki
    Ohno, Tadao
    Hori, Tomokatsu
    NEURO-ONCOLOGY, 2009, 11 (06) : 883 - 883
  • [33] A randomized trial of bevacizumab for newly diagnosed glioblastoma
    Schiff, David
    Huse, Jason
    Wen, Patrick
    NEURO-ONCOLOGY, 2014, 16 (06) : 769 - 770
  • [34] Phase II trial of copper depletion as angiosuppressive treatment in newly diagnosed Glioblastoma Multiforme: Final report.
    Brem, S
    Grossman, SA
    Carson, KA
    New, P
    Phuphanich, S
    Alavi, JB
    Mikkelsen, T
    Priet, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 114S - 114S
  • [35] A randomized phase II trial of efficacy and safety of the immunotherapy ALECSAT as an adjunct to radiotherapy and temozolomide for newly diagnosed glioblastoma
    Werlenius, Katja
    Stragliotto, Giuseppe
    Strandeus, Michael
    Blomstrand, Malin
    Caren, Helena
    Jakola, Asgeir S.
    Rydenhag, Bertil
    Dyregaard, Dorte
    Dzhandzhugazyan, Karine N.
    Kirkin, Alexei F.
    Raida, Martin K.
    Smits, Anja
    Kinhult, Sara
    NEURO-ONCOLOGY ADVANCES, 2021, 3 (01)
  • [36] Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization
    Rahman, Rifaquat
    Trippa, Lorenzo
    Lee, Eudocia Q.
    Arrillaga-Romany, Isabel
    Fell, Geoffrey
    Touat, Mehdi
    McCluskey, Christine
    Wiley, Jennifer
    Gaffey, Sarah
    Drappatz, Jan
    Welch, Mary R.
    Galanis, Evanthia
    Ahluwalia, Manmeet S.
    Colman, Howard
    Nabors, L. Burt
    Hepel, Jaroslaw
    Elinzano, Heinrich
    Schiff, David
    Chukwueke, Ugonma N.
    Beroukhim, Rameen
    Nayak, Lakshmi
    McFaline-Figueroa, J. Ricardo
    Batchelor, Tracy T.
    Rinne, Mikael L.
    Kaley, Thomas J.
    Lu-Emerson, Christine
    Mellinghoff, Ingo K.
    Bi, Wenya Linda
    Arnaout, Omar
    Peruzzi, Pier Paolo
    Haas-Kogan, Daphne
    Tanguturi, Shyam
    Cagney, Daniel
    Aizer, Ayal
    Doherty, Lisa
    Lavallee, Maria
    Fisher-Longden, Brittany
    Dowling, Shanna
    Geduldig, Jack
    Watkinson, Fiona
    Pisano, William
    Malinowski, Seth
    Ramkissoon, Shakti
    Santagata, Sandro
    Meredith, David M.
    Chiocca, E. Antonio
    Reardon, David A.
    Alexander, Brian M.
    Ligon, Keith L.
    Wen, Patrick Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (36) : 5524 - +
  • [37] Phase I/II study of pazopanib and temozolomide in patients with newly diagnosed and resected glioblastoma: Pazoglio trial.
    Saada-Bouzid, Esma
    Frenel, Jean-Sebastien
    Augereau, Paule
    Bourg, Veronique
    Gal, Jocelyn
    Jacquinot, Rique
    Gourmelon, Carole
    Chateau, Yann
    Barriere, Jerome
    Bondiau, Pierre-Yves
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [38] MRI changes in patients with newly diagnosed glioblastoma treated as part a Phase II trial with bavituximab, radiation, and temozolomide
    Ly, Ina
    Cardona, Jonathan
    Beers, Andrew
    Chang, Ken
    Brown, James
    Reardon, David
    Arrillaga-Romany, Isabel
    Dietrich, Jorg
    Forst, Deborah
    Lee, Eudocia
    Jordan, Justin
    Nayak, Lakshmi
    Wen, Patrick
    Batchelor, Tracy
    Curry, William
    Kalpathy-Cramer, Jayashree
    Gerstner, Elizabeth
    NEUROLOGY, 2019, 92 (15)
  • [39] PriCoTTF: A PHASE I/II TRIAL OF TUMOR TREATING FIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA
    Glas, Martin
    Scheffler, Bjoern
    Lazaridis, Lazaros
    Herrlinger, Ulrich
    Pierscianek, Daniela
    Sure, Ulrich
    Proescholdt, Martin
    Hau, Peter
    Hense, Joerg
    Kleinschnitz, Christoph
    Grosu, Anca-Ligia
    Stuschke, Martin
    Kebir, Sied
    NEURO-ONCOLOGY, 2018, 20 : 22 - 22
  • [40] MRI CHANGES IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED AS PART OF A PHASE II TRIAL WITH BAVITUXIMAB, RADIATION, AND TEMOZOLOMIDE
    Ly, Ina
    Cardona, Jonathan
    Beers, Andrew
    Chang, Ken
    Brown, James
    Reardon, David
    Arrillaga-Romany, Isabel
    Dietrich, Jorg
    Forst, Deborah
    Lee, Eudocia
    Jordan, Justin
    Nayak, Lakshmi
    Wen, Patrick
    Batchelor, Tracy
    Kalpathy-Cramer, Jayashree
    Gerstner, Elizabeth
    NEURO-ONCOLOGY, 2018, 20 : 191 - 191
12345